Tysabri raises alarm bells on drug class

Nat Biotechnol. 2005 Apr;23(4):397-8. doi: 10.1038/nbt0405-397.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / classification
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Integrin alpha4 / adverse effects*
  • Integrin alpha4 / metabolism*
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / immunology
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology
  • Natalizumab
  • Nervous System Diseases / chemically induced
  • Nervous System Diseases / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • Integrin alpha4